New York, NY – Global alternative asset manager The Carlyle Group (NASDAQ: CG) has agreed to acquire Johnson &...
The Carlyle Group Agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15 Billion
read more
healthcare transactions
Category
Pharma / Biotech
In Vitro Diagnostic
Medical devices
Health & Nutrition
LAST POSTS
follow US